|Articles|September 19, 2022

SynForU™- HerCare: Empowering "HER" With Clinically Validated Probiotics

Author(s)Synbio

Vulvovaginal Candidiasis (VVC) affects 75% of reproductive-age women, it is especially common during pregnancy due to higher estrogen levels and glycogen content in vaginal secretions. The latest clinical study conducted in pregnant subjects showed that SynForU™-HerCare, Lactobacilli probiotics reduce vulvovaginal symptoms, decrease emotional stress, reduce impairment of daily activities attributed to the infection, and improve defecation times. Download the whitepaper to find out how clinically validated probiotics can promote women's wellness inside-out.


Related to this article

SupplySide Global Vitaquest
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
Laurentia Bliss
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Klaus Neumann
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.